SPOTLIGHT: Nexium formulation wins FDA approval

The FDA has approved a new formulation of Nexium for gastroesophageal reflux disease. Nexium is AstraZeneca's biggest seller. Report

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.